These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents. Russell AS; Maksymowych WP; de Silva M Ann Rheum Dis; 2005 Dec; 64(12):1807. PubMed ID: 16284357 [No Abstract] [Full Text] [Related]
47. When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step? Smolen JS; Weinblatt ME Ann Rheum Dis; 2008 Nov; 67(11):1497-8. PubMed ID: 18854512 [No Abstract] [Full Text] [Related]
48. Treatment of rheumatoid arthritis. Emery P BMJ; 2006 Jan; 332(7534):152-5. PubMed ID: 16424492 [No Abstract] [Full Text] [Related]
49. Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis. Choy E Cytokine; 2004 Nov 21-Dec 7; 28(4-5):158-61. PubMed ID: 15588689 [TBL] [Abstract][Full Text] [Related]
50. Infliximab for rheumatoid arthritis in a patient with tuberculosis. Matsumoto T; Tanaka T; Kawase I N Engl J Med; 2006 Aug; 355(7):740-1. PubMed ID: 16914717 [No Abstract] [Full Text] [Related]
51. [TNF antagonists in therapy of rheumatoid arthritis]. Oberpichler-Schwenk H Med Monatsschr Pharm; 1999 Nov; 22(11):334-9. PubMed ID: 10596266 [No Abstract] [Full Text] [Related]
52. Tumor necrosis factor-α inhibitor-induced antiglomerular basement membrane antibody disease in a patient with rheumatoid arthritis. Nishimura K; Saegusa J; Kawano S; Morinobu A J Rheumatol; 2012 Sep; 39(9):1904-5. PubMed ID: 22942311 [No Abstract] [Full Text] [Related]
53. New drugs for rheumatoid arthritis. Kalil AC N Engl J Med; 2004 Dec; 351(25):2659-61; author reply 2659-61. PubMed ID: 15609422 [No Abstract] [Full Text] [Related]
54. BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis. Bukhari M; Abernethy R; Deighton C; Ding T; Hyrich K; Lunt M; Luqmani R; Kiely P; Bosworth A; Ledingham J; Ostör A; Gadsby K; McKenna F; Finney D; Dixey J; Rheumatology (Oxford); 2011 Dec; 50(12):2311-3. PubMed ID: 21546351 [No Abstract] [Full Text] [Related]
55. Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade: comment on the article by Buch et al. Schiff MH Arthritis Rheum; 2005 Jan; 52(1):364-5; author reply 365. PubMed ID: 15641081 [No Abstract] [Full Text] [Related]
57. Which TNF inhibitor for rheumatoid arthritis? Med Lett Drugs Ther; 2010 May; 52(1338):38-9. PubMed ID: 20467356 [No Abstract] [Full Text] [Related]
58. Recent therapeutic advances in the treatment of rheumatoid arthritis. Jonas BL N C Med J; 2007; 68(6):425-6. PubMed ID: 18236860 [No Abstract] [Full Text] [Related]
59. [Stable remission of early active rheumatoid arthritis treated with etanercept (Enbrel)]. Kaliterna DM Reumatizam; 2008; 55(2):60-1. PubMed ID: 19024277 [TBL] [Abstract][Full Text] [Related]
60. Combination cytokine blockade: the way forward in therapy for rheumatoid arthritis? Taylor PC; Williams RO Arthritis Rheumatol; 2015 Jan; 67(1):14-6. PubMed ID: 25302944 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]